Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Yeji Lee, Michaela Jeong, Jeongeun Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 10, pp. 2085-2096
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 20
Rational design of ICD-inducing nanoparticles for cancer immunotherapy
Zhanzhan Zhang, Zheng Pan, Qiushi Li, et al.
Science Advances (2024) Vol. 10, Iss. 6
Open Access | Times Cited: 14
Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications
Razan Masarwy, Lior Stotsky‐Oterin, Aviad Elisha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 211, pp. 115359-115359
Closed Access | Times Cited: 14
Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity
Yi You, Yu Tian, Rui Guo, et al.
European Heart Journal (2025)
Open Access | Times Cited: 1
Lipid nanoparticles for RNA delivery: Self-assembling vs driven-assembling strategies
Valeria Nele, Virginia Campani, Seyedeh Alia Moosavian, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115291-115291
Open Access | Times Cited: 13
Engineering LNPs with polysarcosine lipids for mRNA delivery
Diana D. Kang, Xucheng Hou, Leiming Wang, et al.
Bioactive Materials (2024) Vol. 37, pp. 86-93
Open Access | Times Cited: 12
Delivery of mRNA Encoding Interleukin-12 and a Stimulator of Interferon Genes Agonist Potentiates Antitumor Efficacy through Reversing T Cell Exhaustion
Bin Wang, Maoping Tang, Qijing Chen, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15499-15516
Closed Access | Times Cited: 9
Lipid nanoparticles for enhancing oral bioavailability
Anushareddy Gangavarapu, Lillian V. Tapia-Lopez, Barnali Sarkar, et al.
Nanoscale (2024) Vol. 16, Iss. 39, pp. 18319-18338
Closed Access | Times Cited: 9
The mRNA vaccine, a swift warhead against a moving infectious disease target
Sheema Mir, Mohammad A. Mir
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 336-348
Open Access | Times Cited: 8
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
Xin Bai, Qijing Chen, Fengqiao Li, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Bioinspired cellular membrane-derived vesicles for mRNA delivery
Xiaomin Xu, Limei Xu, Jingzhi Wang, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3246-3266
Open Access | Times Cited: 7
Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery
Jialiang Wang, Yaopeng Ding, K. Chul Chong, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1148-1148
Open Access | Times Cited: 7
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Unraveling the surface marker signature of cell-derived vesicles via proteome analysis and nanoparticle flow cytometry
Hui-Chong Lau, Ilaria Passalacqua, Jik‐Han Jung, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 6
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Clinical perspective on topical vaccination strategies
Petya Popova, Sunny P. Chen, Suiyang Liao, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115292-115292
Open Access | Times Cited: 5
RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors
Shanthi Ganesh, Min Ju Kim, Jenny Lee, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1895-1916
Open Access | Times Cited: 5
In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia
Jeong Hyeon Lee, Jeong Pil Han
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 3, pp. 239-248
Open Access | Times Cited: 5
Strategies for enhanced gene delivery to the central nervous system
Zhenghong Gao
Nanoscale Advances (2024) Vol. 6, Iss. 12, pp. 3009-3028
Open Access | Times Cited: 5
Optimizing mRNA-Loaded Lipid Nanoparticles as a Potential Tool for Protein-Replacement Therapy
Rocío Celeste Gambaro, Ignacio Rivero Berti, María J. Limeres, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 771-771
Open Access | Times Cited: 5
A single dose of VEGF-A circular RNA sustains in situ long-term expression of protein to accelerate diabetic wound healing
Jinyu Liu, Yanhao Zhang, Chao Liu, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 319-335
Closed Access | Times Cited: 5
Oxidative Stress-Induced Gastrointestinal Diseases: Biology and Nanomedicines—A Review
Maryam Rezvani
BioChem (2024) Vol. 4, Iss. 3, pp. 189-216
Open Access | Times Cited: 5
Ionizable polymeric micelles (IPMs) for efficient siRNA delivery
Ziyu Zhou, Feng Yu, Miao Jiang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
A Novel Approach for In Vitro Testing and Hazard Evaluation of Nanoformulated RyR2-Targeting siRNA Drugs Using Human PBMCs
Valeria Bettinsoli, Gloria Melzi, Angela Maria Antonia Crea, et al.
Life (2025) Vol. 15, Iss. 1, pp. 95-95
Open Access
Page 1 - Next Page

Scroll to top